COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 197 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,468 | +4.0% | 1,050,000 | 0.0% | 0.77% | +5.3% |
Q2 2023 | $22,565 | -10.4% | 1,050,000 | 0.0% | 0.74% | -5.2% |
Q1 2023 | $25,190 | +3.4% | 1,050,000 | 0.0% | 0.78% | -7.2% |
Q4 2022 | $24,360 | -99.9% | 1,050,000 | 0.0% | 0.84% | +62.1% |
Q3 2022 | $16,821,000 | -9.6% | 1,050,000 | 0.0% | 0.52% | -36.2% |
Q2 2022 | $18,606,000 | -13.0% | 1,050,000 | 0.0% | 0.81% | +4.4% |
Q1 2022 | $21,378,000 | +9.0% | 1,050,000 | 0.0% | 0.77% | +14.7% |
Q4 2021 | $19,614,000 | -50.3% | 1,050,000 | -47.5% | 0.67% | -44.6% |
Q3 2021 | $39,480,000 | -16.5% | 2,000,000 | 0.0% | 1.22% | -23.7% |
Q2 2021 | $47,280,000 | -0.3% | 2,000,000 | 0.0% | 1.59% | -2.1% |
Q1 2021 | $47,400,000 | +18.3% | 2,000,000 | 0.0% | 1.63% | +15.7% |
Q4 2020 | $40,060,000 | -51.9% | 2,000,000 | -50.0% | 1.41% | -36.0% |
Q3 2020 | $83,280,000 | +137.9% | 4,000,000 | +100.0% | 2.20% | +9.7% |
Q2 2020 | $35,000,000 | +7.2% | 2,000,000 | 0.0% | 2.00% | +2.7% |
Q1 2020 | $32,660,000 | – | 2,000,000 | – | 1.95% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |